Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.37%)
At close: Sep 4, 2026 · 4:00 PM EDT

Compugen (CGEN) Price to Earnings (2009 - 2026)

Analysis

Compugen (CGEN) Price to Earnings (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Compugen 242.44 Mn 156.82 Mn -92,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9.07
Mar 31, 2026 26.30
Dec 31, 2025 2.55
Sep 30, 2025 -19.08
Jun 30, 2025 -7.37
Mar 31, 2025 18.36
Dec 31, 2024 -22.40
Sep 30, 2024 15.71
Jun 30, 2024 -9.02
Mar 31, 2024 31.71
Dec 31, 2023 18.06
Sep 30, 2023 -8.18
Jun 30, 2023 -3.53
Mar 31, 2023 6.53
Dec 31, 2022 -20.43
Sep 30, 2022 -4.83
Jun 30, 2022 5.60
Mar 31, 2022 -28.66
Dec 31, 2021 -56.10
Sep 30, 2021 -61.10